Work Medical Technology Group LTD 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
NASDAQ
WORK Medical Technology Group LTD filed an amendment to its annual report to include auditor consents from WWC, P.C. and HTL International, LLC.
NASDAQ
WORK Medical Technology Group reported a net loss of $1.2 million for fiscal year 2025, with revenue decreasing by 14.4% to $9.8 million, while pursuing new medical device approvals and strategic partnerships.
NASDAQ
WORK Medical Technology Group LTD's 20-F filing highlights risks associated with PRC regulations, competition, and potential delisting under the Holding Foreign Companies Accountable Act.